DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853
|||||||||
|---|---|---|---|---|---|---|---|
|**Trustees' Annual Report**|||||**for theperiod**|||
|**From **|Period start date|||**To**|Period end date|||
||Day
01|Month
04|Year
2020||Day
31|Month
03|Year
2021|
## Section A Reference and administration details
**Charity name** Mast Cell Action **Other names charity is known by Registered charity number (if any)** 1164917 **Charity's principal address** Mast Cell Action 6 Willes Terrace Leamington Spa **Postcode CV31 1DL**
**Names of the charity trustees who manage the charity**
|1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year**|**Name of person (or body) entitled**
**to appoint trustee(if any)**|
|---|---|---|---|---|
||Gawain Paling|||Trustee of the CIO at a
properly convened meeting of
the charitytrustees|
||Ruth Slater|||Trustee of the CIO at a
properly convened meeting of
the charitytrustees|
||Chris Wood|||Trustee of the CIO at a
properly convened meeting of
the charitytrustees|
||George Hughes|||Trustee of the CIO at a
properly convened meeting of
the charitytrustees|
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
**TAR**
March **2012**
1
DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853
20
**Names of the trustees for the charity, if any, (for example, any custodian trustees)**
|**Name**|**Dates acted if not for whole year**|
|---|---|
|N/A||
|||
|||
## **Names and addresses of advisers (Optional information)**
**Type of adviser Name Address**
## **Name of chief executive or names of senior staff members (Optional information)**
## **Section B Structure, governance and management**
## **Description of the charity’s trusts**
Type of governing document
Constitution
- (eg. trust deed, constitution)
Charitable Incorporated Association How the charity is constituted
- (eg. trust, association, company)
Trustee selection methods
Appointed at Trustees at meeting
- (eg. appointed by, elected by)
## **Additional governance issues (Optional information)**
You **may choose** to include additional information, where relevant, about:
Trustees receive a copy of the constitution and the trustees responsibilities.
- policies and procedures adopted for the induction and training of trustees;
- the charity’s organisational structure and any wider network with which the charity works;
- relationship with any related parties;
- trustees’ consideration of major risks and the system and procedures to manage them.
## **Section C Objectives and activities**
**TAR**
March **2012**
2
DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853
|**Summary of the objects of**
**the charity set out in its**
**governing document**
**Summary of the main**
**activities undertaken for the**
**public benefit in relation to**
**these objects (include**
**within this section the**
**statutory declaration that**
**trustees have had regard to**
**the guidance issued by the**
**Charity Commission on**
**public benefit)**|To lobby for universal awareness, diagnosis and treatment of MCAS.
To provide support for MCAS patients and their families.
To support doctors and researchers with an interest in MCAS.
To persuade the medical community that, by recognising Mast Cell
Activation Syndrome, there will be a huge opportunity for the much
more effective use of resources within the medical system.
To bring the Mast Cell Activation Syndrome patient community
together and create a cohesive voice.|
|---|---|
||The main activities carried out in the financial year were:
Collaborated with medical professionals to develop a children’s
storybook to support families with discussion around MCAS and
associated feelings.
Did a charity raffle
Supported our stake holders remotely through the pandemic
Attended (virtually) an immunology conference.
Improved awareness of MCAS and supported MCAS sufferers
through our online resources.
Brought on additional Volunteers.
Improved our online infrastructure to better make resources available
to our stakeholders.|
## **Additional details of objectives and activities (Optional information)**
You **may choose** to include further statements, where relevant, about:
- policy on grantmaking;
- policy programme related investment;
- contribution made by volunteers.
**TAR**
March **2012**
3
DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853
## Section D Achievements and performance
Created a new series of marketing leaflets on MCAS **Summary of the main** Engaged with many doctors at conferences, raised awareness of the condition. **achievements of the charity** Supported MCAS sufferers **during the year** Produced a film through ITN to raise awareness of MCAS which was shown at the BSACI conference.
Created a series of wellbeing resources to support the MCAS community. Continued to build and support the patient community through our social media groups.
Supported the community by writing to supermarket chains to advocate for the need of specific products which are essential to those living with MCAS – such as free-from foods, bottled water and specific brands of some products.
Supported the community with medication supply issues due to covid by sourcing and sharing accurate and up-to date information.
Developed supportive resources to share through social media.
**TAR**
March **2012**
4
DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853
## **Section E Financial review**
**Brief statement of the**
The Charity has cash reserves held in a current account with a high street bank.
**charity’s policy on reserves**
**Details of any funds materially in deficit**
## **Further financial review details (Optional information)**
You **may choose** to include additional information, where relevant about:
- the charity’s principal sources of funds (including any fundraising);
Fundraising is from the general public from either specific events or ad hoc donations.
Almost all our expenditure is associated with attending medical conferences and the production of materials to help patients, raise awareness and educate doctors.
- how expenditure has supported the key objectives of the charity;
- investment policy and objectives including any ethical investment policy adopted.
## **Section F Other optional information**
## **Section G Declaration**
**The trustees declare that they have approved the trustees’ report above.**
**Signed on behalf of the charity’s trustees**
**Signature(s)** Gawain Paling **Full name(s)** George Hughes **Position (eg Secretary, Chair,** Treasurer Trustee **etc) Date** 27/01/2022
**TAR**
March **2012**
5
DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853
|**Charity Name**
**Mast Cell Action**|**Charity Name**
**Mast Cell Action**|**Charity Name**
**Mast Cell Action**|**No (if any)**
**1164917**|
|---|---|---|---|
|**Receipts andpayments accounts**||||
|**For the period**
**from**|Period start date
4/1/2020|**To**|Period end date
3/31/2021|
**CC16a**
|**Section A Receipts and payments**|**Section A Receipts and payments**|**Section A Receipts and payments**||||||||
|---|---|---|---|---|---|---|---|---|---|
|**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest**
**£**||**Restricted**
**funds**
**to the nearest £**||**Endowment**
**funds**
**to the nearest £**||**Total funds**
**to the nearest £**||**Last year**
**to the nearest £**|
|Donations|**20,113**||**-**||**-**||**20,113**||**-**|
|**_Sub total_**_(Gross income for_
_AR)_|**20,113**||**-**||**-**||**20,113**||**-**|
|||||||||||
|**A2 Asset and investment sales,**
**(see table).**||||||||||
||**-**|||||||||
||**-**||||||||**-**|
|**_Sub total_**|**-**||||||||**-**|
|**_Total receipts_**||||||||||
||**20,113**||||||||**-**|
|**A3 Payments**||||||||||
|---|---|---|---|---|---|---|---|---|---|
|Telephone and internet|**944**||||||**944**|||
|Cost of FundraisingEvents|**8,655**||||||**8,655**|||
|Print, Postage Stationary and
Computer|**6,212**||||||**6,212**|||
|Travel|**59**||||||**59**|||
|Attendance at conferences and events|**592**||||||**592**|||
|Rent/Hire of Rooms|**854**||||||**854**|||
|Consulting|**7,973**||||||**7,973**|||
||||||||**-**|||
||||**-**||**-**||**-**||**-**|
||||**-**||**-**||**-**||**-**|
||||**-**||**-**||**-**||**-**|
||||**-**||**-**||**-**||**-**|
|**_Sub total_ **|**25,289.31**||**-**||**-**||**25,289**||**-**|
|||||||||||
|**A4 Asset and investment**
**purchases, (see table)**||||||||||
||**-**|||||||||
||**-**|||||||||
|**_Sub total_ **|**-**||||||||**-**|
|**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**||||||||||
||||||||||**-**|
|||||||||||
||**- 5,177**||**-**||**-**||**- 5,177**||**-**|
||**-**|
|**-**|
|**-**||**-**||**-**|
||**26,529**||**-**||**-**||**26,529**||**-**|
||**21,352**||**-**||**-**||**21,352**||**-**|
CCXX R1 accounts (SS)
1/27/2022
1
DocuSign Envelope ID: D52B69BD-4EB6-461D-961E-279C7BD29853
## **Section B Statement of assets and liabilities at the end of the period**
|**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B1 Cash funds**
**B2 Other monetary assets**
**B3 Investment assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**|(agree balances with receipts and payments
account(s))
**Details**
**_Total cash funds_**
**Details**|(agree balances with receipts and payments
account(s))
**Details**
**_Total cash funds_**
**Details**|**Unrestricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
Agreement Error
**Unrestricted**
**funds**
**to nearest £**|**Unrestricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
Agreement Error
**Unrestricted**
**funds**
**to nearest £**|**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Restricted**
**funds**
**to nearest £**|**Restricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Restricted**
**funds**
**to nearest £**|**Endowment**
**funds**
**to nearest £**|
|---|---|---|---|---|---|---|---|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||**-**|
||||||||OK|
||||||||**Endowment**
**funds**
**to nearest £**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||||**-**||**-**||**-**|
||**Details**||**Fund to which**
**asset belongs**||**Cost (optional)**||**Current value**
**(optional)**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||**Details**||**Fund to which**
**asset belongs**||**Cost (optional)**||**Current value**
**(optional)**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||||||**-**||**-**|
||**Details**||**Fund to which**
**liability relates**||**Amount due**
**(optional)**||**When due**
**(optional)**|
||||||**-**|||
||||||**-**|||
||||||**-**|||
||||||**-**|||
||||||**-**|||
||Signature||Print Name
George Hughes
Gawain Paling|||||
||||||||Date of
approval|
||||||||1/27/2022|
||||||||1/27/2022|
|||||||||
CCXX R2 accounts (SS)
1/27/2022
2